Analysts: Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

38.40USD
26 Nov 2014
Price Change (% chg)

$2.45 (+6.82%)
Prev Close
$35.95
Open
$35.85
Day's High
$38.80
Day's Low
$35.65
Volume
200,961
Avg. Vol
215,322
52-wk High
$57.89
52-wk Low
$20.88

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.21 December 27 Nov 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 4 10.98 30.00 3.10 17.00
Quarter Ending Mar-15 2 4.15 5.20 3.10 12.20
Year Ending Dec-14 4 21.87 40.89 13.99 35.62
Year Ending Dec-15 4 31.58 57.90 0.00 0.00
Earnings (per share)
Quarter Ending Dec-14 5 -0.21 0.36 -0.47 -0.05
Quarter Ending Mar-15 1 -0.45 -0.45 -0.45 -0.09
Year Ending Dec-14 4 -1.30 -0.67 -1.54 -1.16
Year Ending Dec-15 5 -1.41 -0.59 -2.11 -1.44

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 11.01 3.51 7.50 68.12
Quarter Ending Jun-14 4.10 4.08 0.02 0.54
Quarter Ending Mar-14 2.85 3.31 0.46 16.20
Quarter Ending Dec-13 13.66 11.52 2.14 15.64
Quarter Ending Sep-13 5.52 4.27 1.25 22.69
Earnings (per share)
Quarter Ending Sep-14 -0.27 -0.25 0.02 -7.41
Quarter Ending Jun-14 -0.45 -0.36 0.09 -20.00
Quarter Ending Mar-14 -0.44 -0.30 0.14 -31.82
Quarter Ending Dec-13 -0.08 -0.64 0.56 -753.33
Quarter Ending Sep-13 -0.40 -5.62 5.22 -1,305.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 10.98 10.98 6.16 6.16 17.00
Quarter Ending Mar-15 4.15 4.15 3.90 3.90 12.20
Year Ending Dec-14 21.87 21.87 24.54 24.56 35.62
Year Ending Dec-15 31.58 22.80 22.13 22.14 0.00
Earnings (per share)
Quarter Ending Dec-14 -0.21 -0.21 -0.34 -0.34 -0.05
Quarter Ending Mar-15 -0.45 -0.45 -0.47 -0.47 -0.09
Year Ending Dec-14 -1.30 -1.30 -1.43 -1.43 -1.16
Year Ending Dec-15 -1.41 -1.41 -1.49 -1.49 -1.44

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 1 2
Quarter Ending Mar-15 0 0 1 0
Year Ending Dec-14 0 0 1 3
Year Ending Dec-15 0 0 1 0
Earnings
Quarter Ending Dec-14 0 0 1 1
Quarter Ending Mar-15 0 0 1 0
Year Ending Dec-14 0 0 3 1
Year Ending Dec-15 0 0 4 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks